Klaus Wagner
Chief Tech/Sci/R&D Officer at BOUNDLESS BIO, INC.
Net worth: - $ as of 30/04/2024
Profile
Klaus W.
Wagner is currently the Chief Medical Officer at Boundless Bio, Inc. Prior to his current position, he served as the Chief Medical Officer & Executive Vice President at Inhibrx, Inc. from 2015 to 2022.
Dr. Wagner holds a doctorate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Klaus Wagner active positions
| Companies | Position | Start |
|---|---|---|
| BOUNDLESS BIO, INC. | Chief Tech/Sci/R&D Officer | 20/02/2022 |
Former positions of Klaus Wagner
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 01/02/2022 |
Training of Klaus Wagner
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INHIBRX, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
- Stock Market
- Insiders
- Klaus Wagner
